【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the Protein Kinase Inhibitor Market for Cancer Treatments, 2015
1.2 Benefits of This Report
1.2.1 How This Report Delivers
1.2.2 Main Questions Answered by this Analytical Study
1.3 Who is This Report For?
1.4 Methods of the Study
1.5 Frequently Asked Questions (FAQ)
1.6 Associated Visiongain Reports
1.7 About Visiongain
2. Introduction to Anti-Cancer Kinase Inhibitors
2.1 What are Protein Kinases and Protein Kinase Inhibitors?
2.2 Protein Kinases in Oncology
2.3 Glossary
3. Leading Anti-Cancer Kinase Inhibitor Drugs: Forecasts and Discussions, 2015-2025
3.1 Brc-Abl Inhibitors – Transforming Chronic Myeloid Leukaemia from a Fatal Diagnosis To a Managed Lifestyle
3.1.1 Glivec/Gleevec (imatinib) – Novartis
3.1.2 Sprycel (dasatinib) – Bristol-Myers Squibb
3.1.3 Tasigna (nilotinib) – Novartis
3.1.4 Bosulif (bosutinib) – Pfizer
3.1.5 Iclusig (ponatinib) – ARIAD Pharmaceuticals
3.2 EGFR Inhibitors Target a Mutation-Positive Market
3.2.1 Tarceva (erlotinib) – Roche/Astellas
3.2.2 Iressa (gefinitib) – AstraZeneca
3.2.3 Gilotrif/Giotrif (afatinib) – Boehringer Ingelheim
3.3 Angiogenesis Inhibitors Have a Variety of Indications
3.3.1 Nexavar (sorafenib) – Bayer/Onyx
3.3.2 Sutent (sunitinib) – Pfizer
3.3.3 Votrient (pazopanib) – Novartis
3.3.4 Inlyta (axitinib) – Pfizer
3.4 BRAF and MEK Inhibitors: A Promising Combination
3.4.1 Zelboraf (vemurafenib) – Roche
3.4.2 Mekinist (trametinib) and Tafinlar (dabrafenib) – Novartis
3.5 mTOR Inhibitors Have a New Entrant
3.5.1 Afinitor/Votubia (everolimus) – Novartis
3.5.2 Torisel (temsirolimus) – Pfizer
3.5.3 Zydelig (idelalisib) – Gilead Sciences
3.6 Other Leading Cancer Inhibitors Are a Varied Group
3.6.1 Imbruvica (ibrutinib) – J&J/Pharmacyclics/AbbVie
3.6.2 Jakavi/Jakafi (ruxolitinib) – Novartis/Incyte
3.6.3 Xalkori (crizotinib) – Pfizer
3.6.4 Cometriq (cabozantinib) – Exelixis
3.6.5 Caprelsa (vandetanib) – AstraZeneca
3.6.6 Tyverb/Tykerb (lapatinib) – Novartis
3.6.7 Stivarga (regorafenib) – Bayer
3.6.8 Zykadia (ceritinib, LDK378) – Novartis
3.6.9 Ibrance (palbociclib) – Pfizer
3.6.10 Alectinib (AF802) – Roche
4. Anti-Cancer Kinase Inhibitors: World Market Outlook and Forecast, 2015-2025
4.1 Global Anti-Cancer Kinase Inhibitors Market: Leading Kinase Inhibitors in 2014
4.2 World Anti-Cancer Kinase Inhibitors Market: Revenue Forecasts and Change in Market Shares by Class 2015-2025
4.3 Bcr-Abl Inhibitors Lead the Anti-Cancer Kinase Inhibitors Market in 2015
4.3.1 Drivers and Restraints of the Bcr-Abl Kinase Inhibitors Market 2015-2025
4.4 Novel Kinase Inhibitors Will Dominate the Market As They Cover a Broad Range
4.4.1 Drivers and Restraints of these Other Kinase Inhibitors 2015-2025
5. Leading National Markets for Anti-Cancer Kinase Inhibitors, 2015-2025
5.1 Regional Breakdown of the Global Anti-Cancer Kinase Inhibitors Market, 2014
5.2 World Anti-Cancer Kinase Inhibitors Market: Regional Forecast 2015-2025
5.3 How Will Regional Market Shares Change through to 2025?
5.4 The US Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.4.1 Drivers and Restraints of the US Anti-Cancer Kinase Inhibitors Market 2015-2025
5.5 The EU Anti-Cancer Kinase Inhibitors Market 2015-2025
5.5.1 Drivers and Restraints of the EU Anti-Cancer Kinase Inhibitors Market 2015-2025
5.5.2 German Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.5.3 French Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.5.4 Italian Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.5.5 UK Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.5.6 Spanish Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.6 Japanese Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.7 The Anti-Cancer Kinase Inhibitors Emerging Market: BRIC 2015-2025
5.7.1 China: Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.7.2 India: Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.7.3 Brazil: Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.7.4 Russia: Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
6. Anti-Cancer Kinase Inhibitors: R&D Pipeline, 2015
6.1 Cyclin-Dependent Kinase 4/6 Inhibitors in Development
6.1.1 LEE-011 – Novartis
6.1.2 Abemaciclib (LY2835219) – Eli Lilly
6.2 ALK Inhibitors in Development
6.2.1 Brigatinib (AP26113) – ARIAD Pharmaceuticals
6.3 Bruton’s Tyrosine Kinase and PI3K Inhibitors in Development
6.3.1 Venetoclax (ABT-199/RG7601/GDC-0199)– Roche/AbbVie
6.3.2 Duvelisib (IPI-145) – Infinity Pharmaceuticals/AbbVie
6.3.3 Buparlisib (BKM120) – Novartis
6.3.4 ONO-4059 – ONO Pharmaceutical/Gilead Sciences
6.3.5 Copanlisib (BAY 80-6946) – Bayer
6.3.6 Pictilisib (GDC-0941/RG7321) – Roche
6.3.7 BEZ235 – Novartis
6.4 MEK and BRAF Inhibitors in Development
6.4.1 Cobimetinib (GDC-0973/XL518) – Exelixis/Roche
6.4.2 Encorafenib (LGX818) & Binimetinib (MEK162)– Array BioPharma
6.4.3 Selumetinib (AZD 6244) – AstraZeneca/Array BioPharma
6.5 Other Anti-Cancer Kinase Inhibitors in Development
6.5.1 Volasertib – Boehringer Ingelheim
6.5.2 Neratinib (PB272) – Puma Biotechnology
6.5.3 Tivantinib (ARQ197) – Daiichi Sankyo/ArQule
6.5.4 Dovitinib (TKI258) – Novartis
6.5.5 Dacomitinib – Pfizer
6.5.6 Rociletinib (CO-1686) – Clovis Oncology
6.5.7 Entrectinib (RXDX-101) – Ignyta
6.5.8 INC280 and EGF816 – Novartis
7. Leading Companies in the Anti-Cancer Kinase Inhibitors Market, 2015
7.1 Leading Companies in the Anti-Cancer Kinase Inhibitors Market by Revenue, 2014
7.1.1 Leading Anti-Cancer Kinase Inhibitors Manufacturers: Revenue Forecasts, 2015-2025
7.2 Leading Anti-Cancer Kinase Inhibitor Company Profiles
7.2.1 Novartis: Interesting Developments and a Continued Lead on the Market
7.2.2 Pfizer: Advancing Closer to Novartis’ Lead
7.2.3 Roche: A Global Giant in Cancer Treatment
7.2.4 Bristol-Myers Squibb’s Success is Tied to Sprycel
7.2.5 Bayer Healthcare: Nexavar and Stivarga
7.2.6 AstraZeneca Needs the US Market To Succeed
7.2.7 Gilead Sciences
7.3 Other Companies
7.3.1 AbbVie
7.3.2 Boehringer Ingelheim BioXcellence
8. Qualitative Analysis of the Anti-Cancer Kinase Inhibitors Market, 2015-2025
8.1 SWOT Analysis of the Anti-Cancer Kinase Inhibitors Market
8.2 Strengths
8.2.1 Personalised Medicine is a Strong Trend in Cancer Treatment
8.2.2 Targeted Kinase Inhibitors are Generally Well-Tolerated
8.2.3 Strong Pipeline of Novel Inhibitors Will Drive Market Growth
8.2.4 Oral Dosage is the Preferred Treatment
8.3 Weaknesses
8.3.1 High-Cost of Treatment May Restrain the Market
8.3.2 Ease of Manufacturing Small Molecule Drugs
8.3.3 Monoclonal Antibodies are More Specific than Small Molecules
8.4 Opportunities
8.4.1 Ageing Populations and Rising Cancer Prevalence Will Increase Demand for Treatment
8.4.2 Investment into Research May Lead to Improved Targeted Treatments
8.4.3 Combination Therapies Bring Additive Benefits
8.5 Threats
8.5.1 Regulations: Can they Restrain the Market?
8.5.2 Multiple Companies Competing
8.6 STEP Analysis of the Anti-Cancer Kinase Inhibitors Market
9. Research Interviews
9.1 Interview with Dr Lawrence Bloch, Chief Finance and Business Officer, Infinity Pharmaceuticals, United States
9.1.1 Positioning a Novel Therapeutic in Blood Cancer Indications
9.1.2 Combining Therapies Offers Significant Benefit to Patients
9.1.3 Potential in Rheumatoid Arthritis and Blood Cancers
9.2 Interview with Dr Marcel Spaargaren, Associate Professor, LYMMCARE (Lymphoma and Myeloma Center Amsterdam)
9.2.1 Combining Two Kinase Inhibitor Therapeutics
9.2.2 Expectations for Kinase Inhibitor Therapies as Cancer Treatments
9.2.3 The Future of B-Cell Receptor Inhibitors
10. Conclusions from the Research and Analysis
10.1 World Anti-Cancer Kinase Inhibitors Market: Outlook from 2015
10.1.1 Recent Launches of Innovative Drugs and a Robust Pipeline Will Drive Market Growth
10.2 Opportunities in Developed and Developing National Pharma Markets Expanding Those Drug Sales
【レポート販売概要】
■ タイトル：がん治療用キナーゼ阻害剤の世界市場■ 英文：Kinase Inhibitors for Cancer Treatment: World Industry Analysis, R&D and Market Forecasts 2015-2025
: Explore the Potentials of New Drugs
■ 発行日：2015年8月
■ 調査会社：visiongain
■ 商品コード：VGAIN5081916
■ 調査対象地域：グローバル
- MEG Energy Corp.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013MEG Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary MEG Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- 世界の弾性接着剤及びシーラント市場2015The Global Elastic Bonding Adhesive & Sealant Industry Report 2015 is a professional and in-depth study on the current state of the Elastic Bonding Adhesive & Sealant industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Elastic Bonding Adhesive & Sealant market analysis is provided for the international …
- BRIC地域の人工心臓弁処置動向（～2020）BRIC Prosthetic Heart Valve Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Prosthetic Heart Valve Procedures Outlook to 2020", provides key procedures data on the BRIC Prosthetic Heart Valve Procedures. The report provides procedure volumes within market categories - Conventional Mitral Valve (Mitral Valve Re-repair, Mitral Valve Annuloplasty, Mitral Valve Repair, Mitral Valve R …
- 水溶性フィルムの世界市場2016-2020About Water Soluble Films Water soluble films possess dimensional stability, reduced toxicity, have a high moisture and gas barrier, and are biodegradable, and easy to use. These advanced films are used to package goods like dyes, agrochemicals, laundry, electrical appliances, and linen bags. Agrochemical, water treatment chemicals, and detergent packages are key end-users of water soluble films. …
- インドの農業の機械化市場2016-2020About Farm Mechanization The global farm mechanization market is largely dependent on agricultural land and farm output. Global agricultural production affects the market substantially as it grows in tandem with the demand for food. However, in various phases, the global agricultural production has slowed down in recent years as the demand for agricultural products has decreased. Recent environmen …
- 世界におけるモバイルDRAM市場動向およびメーカー戦略The earliest application of DRAM (Dynamic Random Access Memory) can be traced back to the PC age. As the PC market declines, new types of mobile devices have taken over to become the world's most popular electronics products thanks to their versatile characteristics, high levels of convenience, and the stylish design. The popularity of mobile devices has led to fast growth for mobile DRAMs, turnin …
- 頭蓋内圧（ICP）モニタリング装置の世界市場分析：方法別（侵襲的、非侵襲的）、用途別（外傷性脳傷害、脳内出血、髄膜炎、くも膜下出血、その他）、セグメント予測、2014-2025The global intracranial pressure monitoring devices market is expected to reach USD 1.9 billion 2025, according to a new report by Grand View Research, Inc. Increasing neurological disorders and growing awareness regarding various treatment options available is spurring the growth of these devices on a global level. In addition, constant rise in patient numbers suffering from severe brain diseases …
- モノマー市場動向：December 2012Monomer World – December 2012 Summary Global monomer prices were boosted by restricted supplies in December 2012, aided by improving demand in key regions. In most regions, the tight supply conditions were attributed to low operating rates and numerous plants undergoing maintenance turnarounds. Scope - Analyses monthly price trends in Asia, Europe and North America region - Details significant dev …
- 世界における医療保険取引IT市場動向及び予測（～2018）The global HIX ITmarket is valued at an estimated $1,609 million in 2013 and is expected to grow at a CAGR of 10.5% in the next five years. The global HIX IT market is mainly categorized by exchange type, phase, component, and end user. Private exchanges are expected to register the fastest growth rate among the HIX market by exchange type during the forecast period.Their favorable growth is attri …
- 対UAV（無人機）防衛システムの世界市場2016-2020About Counter UAV Defense System Counter UAV defense systems detect potential unmanned aerial vehicle (UAV) threats and find application in industries like military, homeland security, and airports. The system is a combination of radars, infrared cameras, and navigators that recognize drones and limit their risk capabilities. Jamming systems and technologies also play a pivotal role to ensure that …
- 性機能強化サプリメントの世界市場2017-2021ABSTRACTAbout Sexual Enhancement Supplements These supplements include creams, gels, and sprays that are available in a variety of flavors and colors in the market, and sold through online and retail outlets. Here, the internet plays a major role in driving the market growth. It not only gives buyers access to a broad range of sexual enhancement supplements, but it also helps supplements providers …
- タレントマネジメントソフトウェアの世界市場2019-2023Global Talent Management Software Market 2019-2023: About the market Technavio’s talent management software market analysis considers sales from both cloud-based and on-premise. Our analysis also considers the sales of talent management software in APAC, Europe, MEA, North America, and South America. In 2018, the cloud-based segment had a significant share, and this trend is expected to continue o …
- PVDCコートフィルムおよびアクリルコートフィルムの世界市場予測（～2023年）’’The PVDC coated films market is projected to register a CAGR of 6.0% and the acrylic coated films market is projected to register a CAGR of 6.5%, in terms of value between 2018 and 2023.’’ The PVDC coated films market size is estimated to be USD 1.5 billion in 2018 and is projected to reach USD 1.9 billion by 2023, at a CAGR of 6.0%. The acrylic coated films market size is estimated to be USD 71 …
- 臨床試験アウトソーシングサービスの世界市場2015-2025Clinical Trials – Discover Commercial Potentials of Outsourced Drug Testing, Benefiting Your Authority What does the future hold for pharmaceutical clinical research providers? Visiongain’s new study gives you multilevel revenue forecasts from 2015 to 2025. It explains trends, opportunities and selling prospects for that drug development and testing. Our report predicts sales at overall world mark …
- 世界の香水（香料）市場：ニュース、イベント動向（2014年3月）Synopsis The report provides a review of the latest news and key events in the global fragrances market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global fragrances market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global …
